Exchanges
BSE, NSE
Industry
Pharmaceuticals
Issue
Book building

Hexagon Nutrition IPO

₹53.19

+18.20% on listing

Listing-day close · NSE · 12 Jun 2026 · issue price ₹45

Hexagon Nutrition’s ₹139 crore IPO was priced at ₹45 a share. It listed on the NSE on 12 Jun 2026 and closed its first day at ₹53.19, up 18.20% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹139 Cr
Fresh issue
—
Offer for sale
₹139 Cr
Lot size
333 shares
Minimum investment
₹14,985
Face value
₹1
Registrar
Kfin Technologies

Subscription

Hexagon Nutrition IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—37.47×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹553 Cr
P/E (post-issue)
15.3
EPS (post-issue)
₹2.93
Price to book
2.5
ROE
13.02%
ROCE
14.82%
Debt to equity
0.18
EBITDA margin
14.03%
PAT margin
9.81%
Promoter holding
89.41% → 45.74%

Financials as of 31 Dec 2025, from the offer documents.

Listing

Listing date
12 Jun 2026
Issue price
₹45
Open
₹53.19
High
₹53.19
Low
₹53.19
Close
₹53.19

Listing day on the NSE. The close was +18.20% on the issue price.

FAQs

When did the Hexagon Nutrition IPO open and close?

It opened on 5 Jun 2026 and closed on 9 Jun 2026.

What was the Hexagon Nutrition IPO price?

The price band was ₹42–45 a share. The final issue price was ₹45.

What is the lot size and minimum investment?

One lot is 333 shares, ₹14,985 at ₹45 a share. Retail investors apply in whole lots.

How much did Hexagon Nutrition raise?

₹139 crore: ₹139 crore offered by existing shareholders.

How many times was the Hexagon Nutrition IPO subscribed?

37.47 times overall.

How did Hexagon Nutrition list?

It listed on the NSE on 12 Jun 2026 at ₹53.19 and closed the day at ₹53.19, up 18.20% on the ₹45 issue price.

Who is the registrar of the Hexagon Nutrition IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app